Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony F Yu

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2018
Risk-Imaging Mismatch: Why Is There a Disconnect?Chau T Dang, Anthony F Yu, Jennifer Liu, et al.
Current Opinion in Cardiology|May 15, 2019
Cardiotoxicity of HER2-targeted therapiesRobert S Copeland-Halperin, Jennifer E Liu, Anthony F Yu
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 1, 2017
Cardiac ATTR amyloid nuclear imaging-not all bone scintigraphy radionuclide tracers are created equalJi Can Yang, Josef Fox, Carol Chen, et al.
The Oncologist|August 19, 2018
In ReplyChau T Dang, Jasmeet C Singh, Richard M Steingart, et al.
The Journal of Nutrition|November 8, 2002
Enzymes and metabolites of cysteine metabolism in nonhepatic tissues of rats show little response to changes in dietary protein or sulfur amino acid levelsMartha H Stipanuk, Monica Londono, Jeong-In Lee, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 3, 2003
The ubiquitin-proteasome system is responsible for cysteine-responsive regulation of cysteine dioxygenase concentration in liverMartha H Stipanuk, Lawrence L Hirschberger, Monica P Londono, et al.
Breast Cancer Research and Treatment|February 6, 2019
Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fractionYasin Hussain, Esther Drill, Chau T Dang, et al.
Future Cardiology|June 2, 2017
Management of ischemic coronary disease in patients receiving chemotherapy: an uncharted clinical challengeBibhu D Mohanty, Sudipta Mohanty, Yasin Hussain, et al.
The Oncologist|November 8, 2025
Association of early dexrazoxane with reduced cardiotoxicity risk in sarcoma patients treated with anthracycline chemotherapyKristine H Jang, Joseph S Wallins, I-Hsin Lin, et al.
Journal of the American Heart Association|April 16, 2025
Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy-Related Cardiac DysfunctionIshmam Ibtida, Xiaoyue Ma, Mohammed Al-Sadawi, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2018
Risk-Imaging Mismatch: Why Is There a Disconnect?Chau T Dang, Anthony F Yu, Jennifer Liu, et al.
Current Opinion in Cardiology|May 15, 2019
Cardiotoxicity of HER2-targeted therapiesRobert S Copeland-Halperin, Jennifer E Liu, Anthony F Yu
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 1, 2017
Cardiac ATTR amyloid nuclear imaging-not all bone scintigraphy radionuclide tracers are created equalJi Can Yang, Josef Fox, Carol Chen, et al.
The Oncologist|August 19, 2018
In ReplyChau T Dang, Jasmeet C Singh, Richard M Steingart, et al.
The Journal of Nutrition|November 8, 2002
Enzymes and metabolites of cysteine metabolism in nonhepatic tissues of rats show little response to changes in dietary protein or sulfur amino acid levelsMartha H Stipanuk, Monica Londono, Jeong-In Lee, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 3, 2003
The ubiquitin-proteasome system is responsible for cysteine-responsive regulation of cysteine dioxygenase concentration in liverMartha H Stipanuk, Lawrence L Hirschberger, Monica P Londono, et al.
Breast Cancer Research and Treatment|February 6, 2019
Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fractionYasin Hussain, Esther Drill, Chau T Dang, et al.
Future Cardiology|June 2, 2017
Management of ischemic coronary disease in patients receiving chemotherapy: an uncharted clinical challengeBibhu D Mohanty, Sudipta Mohanty, Yasin Hussain, et al.
The Oncologist|November 8, 2025
Association of early dexrazoxane with reduced cardiotoxicity risk in sarcoma patients treated with anthracycline chemotherapyKristine H Jang, Joseph S Wallins, I-Hsin Lin, et al.
Journal of the American Heart Association|April 16, 2025
Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy-Related Cardiac DysfunctionIshmam Ibtida, Xiaoyue Ma, Mohammed Al-Sadawi, et al.
Pageof 7